Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3830f35387a1c32061dea3ee310851 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16134 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10345 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2810-6018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2810-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2810-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2810-6054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-21 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
filingDate |
2007-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09fc4ac0c4e08cf51f4d4e410ec498d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4572ab64a7732d2d1006c62d263f27dd |
publicationDate |
2009-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2012822-A2 |
titleOfInvention |
Modified adenovirus hexon protein and uses thereof |
abstract |
The present invention provides a method of altering the specificity of an adenovirus vector. The method involves providing an adenovirus having a capsid with a modified adenovirus hexon protein. The modified adenovirus has a capsid comprising a hexon protein with a deletion in hypervariable region 1 and/or hypervariable region 4 of the hexon and an insert of an exogenous molecule therein. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9206238-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8470310-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8846031-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9593346-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10149873-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8231880-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8524219-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8940290-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9382551-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8685387-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9359618-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10501757-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11077156-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8834863-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9597363-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9217159-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11401529-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10113182-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11130968-B2 |
priorityDate |
2006-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |